FAQs for country leaders

If you’re interested in becoming a May Measurement Month 2017 country leader, here are some FAQs to help you find out more…


What is May Measurement Month?

May Measurement Month is a worldwide screening initiative led by the International Society of Hypertension (ISH) and World Hypertension League (WHL) aimed at highlighting the need for increased blood pressure awareness.

This is important because — as you’ll be aware — hypertension kills more people per year (nearly 10 million around the world) than any other single cause and represents the biggest contributing risk factor to the global burden of disease.

We know that many people are unaware that they have high blood pressure and some only find out after they suffer a heart attack or stroke, or are diagnosed with something else, such as heart or kidney disease, or dementia.

Or — far worse — they die never knowing that just having their blood pressure measured could have saved their lives.

By measuring as many people as possible and finding out just how big the ‘hidden hypertension’ problem is, we aim to demonstrate to governments across the world why they need to raise public awareness and provide us all with better blood pressure screening facilities and treatment.

May Measurement Month will run for the first time from 1-31 May 2017 and builds on the WHL’s established World Hypertension Day which takes place every year on 17 May. Our aim is to establish May Measurement Month as an annual event that will grow in stature and reach year on year.


How will May Measurement Month work?

During May 2017, our goal is to screen millions of adults aged 18 and over across the world. We are primarily focused on people who have not had their blood pressure measured since April 2015.

We are using a simple protocol, with measurements recorded using a specially-designed app. Screenings will take place at a range of centres such as pharmacies, workplaces, shopping centres, and clinics and will be carried out by volunteers from a medical background. Among them will be doctors, nurses, and medical students.

It’s anticipated we’ll identify a significant number of new cases of hypertension during May Measurement Month 2017 and we are confident their systolic measurements can be lowered by an average of 10 mmHg just by us helping them seek the right treatment, so saving thousands of major adverse cardiovascular events.

We are now looking for volunteers who share our vision to take the lead in their country and help us make the first May Measurement Month just the starting point in a continuing global campaign.


How are you using the May Measurement Month data?

All the data collected remains anonymous — you can find out exactly how the process will work in our May Measurement Month informed consent and protocol documents.

The project offers a unique opportunity to collate data from multiple locations and will provide unprecedented insight at global, national, and regional level, as well as generating unique gender, age and ethnicity variables.

We envisage several major pieces of research arising from May Measurement Month, with publication in leading medical journals. This includes at least one paper in The Lancet — with all the leading national contributors as co-authors — and the opportunity for many more to be featured at local level.

Key players in May Measurement Month can expect to be named in at least five publications.


If I get involved, are there any immediate benefits?

We are providing all our screening centres with new automatic BP machines free of charge, and these can be left on site for future use outside May Measurement Month.


And what about long-term benefits?

We hope to use the data we collect during May Measurement Month to help fast-track the development of an affordable, single-pill, two-drug combination of antihypertensive agents to give sustainable support in those countries where this type of medication is not currently available.

As May Measurement Month matures, it will allow new alliances and partnerships to form among practitioners and international healthcare providers, and will also help strengthen the authority of national hypertension, cardiac and renal societies.

At a global level, we envisage a significant increase in the impact the ISH and WHL can have on the prevention, treatment, and control of hypertension.


I’m interested! What do I do next?

Please contact us at mmminfo@ish-world.com and we will connect you with the ISH Regional Action Group leader responsible for your country.


You can download these FAQs as a PDF here…